Your browser doesn't support javascript.
loading
Building an integrated serosurveillance platform to inform public health interventions: Insights from an experts' meeting on serum biomarkers.
Wiens, Kirsten E; Jauregui, Barbara; Arnold, Benjamin F; Banke, Kathryn; Wade, Djibril; Hayford, Kyla; Costero-Saint Denis, Adriana; Hall, Robert H; Salje, Henrik; Rodriguez-Barraquer, Isabel; Azman, Andrew S; Vernet, Guy; Leung, Daniel T.
  • Wiens KE; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
  • Jauregui B; Mérieux Foundation USA, Washington, District of Columbia, United States of America.
  • Arnold BF; Francis I. Proctor Foundation, University of California, San Francisco, California, United States of America.
  • Banke K; Department of Ophthalmology, University of California, San Francisco, California, United States of America.
  • Wade D; Bill & Melinda Gates Foundation, Seattle, Washington, United States of America.
  • Hayford K; Institut de Recherche en Santé, de Surveillance Epidémiologique et de Formation (IRESSEF), Dakar, Senegal.
  • Costero-Saint Denis A; International vaccine access center (IVAC), Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
  • Hall RH; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States of America.
  • Salje H; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States of America.
  • Rodriguez-Barraquer I; Department of Genetics, University of Cambridge, Cambridge, United Kingdom.
  • Azman AS; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, California, United States of America.
  • Vernet G; Division of Experimental Medicine, University of California, San Francisco, California, United States of America.
  • Leung DT; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
PLoS Negl Trop Dis ; 16(10): e0010657, 2022 10.
Article en En | MEDLINE | ID: mdl-36201428
ABSTRACT
The use of biomarkers to measure immune responses in serum is crucial for understanding population-level exposure and susceptibility to human pathogens. Advances in sample collection, multiplex testing, and computational modeling are transforming serosurveillance into a powerful tool for public health program design and response to infectious threats. In July 2018, 70 scientists from 16 countries met to perform a landscape analysis of approaches that support an integrated serosurveillance platform, including the consideration of issues for successful implementation. Here, we summarize the group's insights and proposed roadmap for implementation, including objectives, technical requirements, ethical issues, logistical considerations, and monitoring and evaluation.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Salud Pública / Enfermedades Transmisibles Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Salud Pública / Enfermedades Transmisibles Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article